fashion -WSS

fashion

author：entertainment 2025-08-21 08:27:09 - browse：68271

STAT's Casey Ross (left) and Kimberly Powell, NVIDIA's vice president for healthcare at the STAT Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — In the world of drug discovery, AI progress is often measured by a single-mile marker: When will we get an AI-designed drug?

The answer remains, ambiguously, “the future,” but at STAT’s Breakthrough Summit leaders from NVIDIA and Google insisted that the impact of AI is visible today.

Kimberly Powell, vice president of healthcare for NVIDIA, pointed to an increase in investigational new drug applications filed with the Food and Drug Administration that cite AI, as well as an uptick in early-stage readouts from clinical trials, as evidence of progress. Some of the recent readouts, Powell said, show that what’s going into Phase 1 clinical trials is more successful.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Listen: A conversation with researcher Kevin Esvelt on biosecurity

WSS

FDA poised to publish guidelines for clinical trial diversity

FDA endorses new sterilization method for medical devices

As a primary care physician, here's how I hope to partner with AI

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

To bolster infectious disease surveillance, genomics powerhouses team up

A pediatrician calls for Congress to pass the child tax credit deal

focus

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

As a primary care physician, here's how I hope to partner with AI

Continuity nursing helped my family in our darkest PICU moments

ASCO eve: Let’s set the table for this year's meeting

In Memoriam: Notable people who died in 2023

Listen: More tumult at BIO & coercive care for sickle cell patients

Dobbs anniversary: the lost opportunity of abortion as health care

Reports of telehealth's death have been greatly exaggerated

Affirmative action in medical school literally saved lives

Dana Farber says 6 studies to be retracted and 31 corrected

entertainment

HPV vaccine, cervical cancer study delivers historic results

As a primary care physician, here's how I hope to partner with AI

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

High breast density mammograms need follow

FDA sets aggressive timeline for overhauling inspection procedures

focus

focus

knowledge

entertainment